Breaking News
February 23, 2019 - AHA News: Why Are Black Women at Higher Risk of Dying From Pregnancy Complications?
February 23, 2019 - NIMH » Anxiety Disorders
February 23, 2019 - Autistic people urgently need access to tailored mental health support
February 23, 2019 - Newly designed molecule could benefit people with Friedrich’s Ataxia
February 23, 2019 - Chinese CRISPR twins may have better cognition and memory
February 23, 2019 - Study finds new genetic clues associated with asthma in African ancestry populations
February 23, 2019 - Fetal signaling pathways may offer future opportunities to treat lung damage
February 23, 2019 - Early-stage osteoarthritis drug wins prestigious innovation award
February 23, 2019 - Researchers report positive findings with dasotraline for ADHD in children ages 6-12
February 23, 2019 - News study reanalyzes the effects of noncaloric sweeteners on gut microbiota
February 23, 2019 - New device allows scientists to reproduce blow effects on the heart in lab
February 23, 2019 - Holy herb identified as a potential treatment for Alzheimer’s disease
February 23, 2019 - New technology platform digitally counts growth factors in single cells
February 23, 2019 - Surgery and other treatments offer viable options for adult scoliosis
February 23, 2019 - Reduced antibody adaptability may make the elderly more vulnerable to influenza
February 23, 2019 - Neighborhood income, education associated with risk of disability progression in MS patients
February 23, 2019 - 2019 guidelines for management of patients with atrial fibrillation
February 23, 2019 - Surprise rheumatoid arthritis discovery points to new treatment for joint inflammation
February 23, 2019 - A just-right fix for a tiny heart
February 23, 2019 - UMass Amherst scientist explores role of citrus peel in decreasing gut inflammation
February 23, 2019 - Owlstone Medical and Shanghai Renji Hospital collaborate to initiate breath biopsy lung cancer trial
February 23, 2019 - AMSBIO’s comprehensive portfolio of knock-out cell lines and lysates
February 23, 2019 - New app reliably determines physicians’ skills in forming accurate, efficient diagnoses
February 23, 2019 - Peripheral nerve injury can trigger the onset and spread of ALS, shows study
February 23, 2019 - Researchers uncover mechanisms that prevent tooth replacement in mice
February 23, 2019 - Once-a-day capsule offers new way to reduce symptoms of chronic breathlessness
February 23, 2019 - FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)
February 23, 2019 - Phone-based intervention aids rheumatoid arthritis care
February 23, 2019 - Opioid epidemic makes eastern inroads and targets African-Americans
February 23, 2019 - New identified biomarker predicts patients who might benefit from HER2-targeted agents
February 23, 2019 - Study offers new insights into mechanisms of changes in erythrocytes under stress
February 23, 2019 - Antipsychotic polypharmacy may be beneficial for schizophrenia patients
February 23, 2019 - Researchers investigate how marijuana and tobacco co-use affects quit attempts by smokers
February 23, 2019 - Patients with diabetes mellitus have high risk of stable ischemic heart disease
February 23, 2019 - Transparency on healthcare prices played key role in Arizona health system’s turnaround
February 23, 2019 - A comprehensive, multinational review of peppers around the world
February 23, 2019 - Study finds modest decrease in burnout among physicians
February 23, 2019 - A simple change can drastically reduce unnecessary tests for urinary tract infections
February 23, 2019 - Deep Learning-Enhanced Device Detects Diabetic Retinopathy
February 23, 2019 - Researchers discover new binding partner for amyloid precursor protein
February 23, 2019 - Modest decrease seen in burnout among physicians, researchers say | News Center
February 23, 2019 - Transplanting bone marrow of young mice into old mice prevents cognitive decline
February 23, 2019 - Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding
February 23, 2019 - Johns Hopkins study describes cells that may help speed bone repair
February 23, 2019 - Scientists demonstrate influence of food odors on proteostasis
February 23, 2019 - Researchers unlock the secret behind reproduction of fish called ‘Mary’
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles

Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles

image_pdfDownload PDFimage_print

A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles. The team has developed the so-called “upconverting” nanoparticles that not only convert infrared light into UV-visible light, but also are water-soluble, remain stable in complex body fluids such as blood serum, and can be used to store medications. They have created a tool that could potentially make the fight against cancer significantly more effective. The researchers recently published their results in the journal Angewandte Chemie (DOI: 10.1002 / anie.201811003).

Nanoparticles are tiny structures, typically less than 100 nanometers in size, which is about 500 to 1000 times smaller than the thickness of a human hair. Such materials are receiving increasing attention for biomedical applications. If equipped with appropriate properties, they can reach almost any tissue in the human body via the bloodstream – turning into perfect body probes.

It has been known for some years that the distribution of nanoparticles in the body is essentially determined by their size and surface properties. Dr. Tanmaya Joshi at HZDR’s Institute for Radiopharmaceutical Cancer Research says, “Upconverting nanomaterials are of great interest for biomedical imaging”. “When stimulated with infrared light they can send out bright blue, green, or red signals. If we succeed in navigating such nano-probes to diseased tissues, it can be particularly useful for cancer diagnosis”, the team’s photochemist, Dr. Massimo Sgarzi, added.

However, these light upconverters show poor solubility in water or tissue fluids – a must to have feature before any diagnostic or therapeutic use could be imagined. For the HZDR team this was not a hindrance, but rather a challenge: “We used a unique polymer mixture to cover the particles,” says Dr. Joshi, who joined HZDR in 2017 from Monash University, as a Humboldt Fellow. Adding this protective cover makes the light-transducing nanoparticles biocompatible. The biologist Dr. Kristof Zarschler adds: “The upconverters are now water-soluble and even have a neutral surface charge. Our research shows that this new cover can almost completely prevent the body’s own substances (present in the blood serum) from binding to the particles. In other words, the nanoparticles now seem to wear an invisibility cloak. This, we believe, will help to avoid their recognition and elimination by phagocytes of the immune system. “

In order to keep the new nano-probes stable for weeks in a complex biological environment, the scientists photochemically link the components of the protective shell with each other: “We simply irradiated our nanoparticles with UV light. This creates additional bonds between the molecular components constituting the protective cover – much alike sewing together the individual parts of the cloak of invisibility with the help of light, “explains the PhD student, Anne Nsubuga. She further adds, “This shell is only a few nanometers thick, and may even be used for hiding other substances, for example, cancer drugs, which could be later on released in the tumour and destroy it.”

Following this breakthrough, the team now intends to validate their current results in living organisms: “For this, we first have to carry out strictly regulated and ethically acceptable experiments on animals. Only when our stealth-cap technology works on these without any side effects, their medical potential will be explored in detail and their application on the patients can be considered”, explains the group leader Dr. Holger Stephan cautiously.

Source:

https://www.hzdr.de/db/Cms?pNid=99&pOid=57187

Tagged with:

About author

Related Articles